Communicable Episode 20: Tuberculosis today

Communicable Episode 20: Tuberculosis today

Saved in:

Bibliographic Details
Main Authors:	Kathryn Hostettler, Lorenzo Guglielmetti, Olha Konstantynovska, Navaneeth Narayanan, Angela Huttner
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	CMI Communications
Subjects:	Tuberculosis Tuberculosis infection Tuberculosis disease Mycobacterium tuberculosis MDR-TB pre-XDR TB
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950590925000320
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia
by: Laura Gillini, et al.
Published: (2013-03-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Investigating the Mutations in atpE and Rv0678 Genes in Mycobacterium Tuberculosis Clinical Isolates
by: Nahid Madadi-Goli1, 2, 3, et al.
Published: (2023-12-01)

Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review
by: Michalik, Maciej, et al.
Published: (2025-06-01)

The New Definition and Epidemiology of Extensive Drug Resistant Tuberculosis in 2020
by: S. A. Sterlikov, et al.
Published: (2023-04-01)

TUBERCULOSIS WITH CONCURRENT HIV INFECTION IN RUSSIA: STATISTICS AND CORRELATIONS
by: E. B. Tsybikova, et al.
Published: (2019-01-01)

Study of fluoroquinolones resistance in rifampicin‐resistant tuberculosis patients in Beijing: Characteristics, trends, and treatment outcomes
by: Wang Nenhan, et al.
Published: (2025-05-01)

Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyResearch in context
by: Yousra Kherabi, et al.
Published: (2025-09-01)

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy
by: L. Kuksa, et al.
Published: (2025-03-01)

Characterization of drug susceptibility of Mycobacterium tuberculosis isolated from new cases of tuberculosis concurrent with HIV infection
by: G. V. Panov, et al.
Published: (2015-02-01)

Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis
by: P. K. Yablonskiy, et al.
Published: (2024-03-01)

QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis
by: A. V. Kukurika
Published: (2024-03-01)

Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013
by: Mohammed Yahya Areeshi, et al.
Published: (2014-09-01)

Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review
by: Salman Daneshi, et al.
Published: (2025-08-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Isoniazid-resistant TB and associated factors in Ethiopia
by: S. Moga, et al.
Published: (2025-06-01)

Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
by: А. Yu. Savchenko, et al.
Published: (2024-01-01)

Incipient and subclinical tuberculosis: a narrative review
by: Malay Sarkar
Published: (2025-01-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)

Tuberculosis multirresistente en adolescente: A propósito de un caso
by: Lorena García-Agudelo
Published: (2025-02-01)

Genotypic and Phenotypic Methods in the Detection of MDR-TB and Evolution to XDR-TB
by: Natalia Zaporojan, et al.
Published: (2025-07-01)

Current innovations in medical laboratory diagnosis of Tuberculosis
by: Obadire, S.O.* , Mitsan, O. , Ige, I.P. , Oke, O.C. , Odewusi, F.O.
Published: (2022-11-01)

Historical examination of tuberculosis; from ancient affliction to modern challenges
by: Seyyed Mohammad Amin Mousavi-Sagharchi, et al.
Published: (2025-03-01)

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Tuberculosis and Impact of COVID-19 on Spread of Epidemics in Kazakhstan
by: Zhandarbek Bekshin, et al.
Published: (2025-06-01)

XDR TB in South Africa - What lies ahead?
by: V. Thaver, et al.
Published: (2007-12-01)

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis
by: Tomasz Bogiel, et al.
Published: (2025-06-01)

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB
by: A. Vasquez, et al.
Published: (2024-07-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)

Detection of Resistant Prevalent Genes for Mycobacterium Tuberculosis by Line Probe Assay
by: Tejaswini A. Olambe, et al.
Published: (2025-03-01)

The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis
by: Azhar Iqbal, et al.
Published: (2022-04-01)

Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world
by: S. A. Sterlikov, et al.
Published: (2016-01-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

Impact of US funding cuts and stop work orders on TB services and research in South Africa
by: N. Ndjeka, et al.
Published: (2025-04-01)

The Role of Risk Factors in the Development of Tuberculosis in Children Exposed to Rifampicin Resistant Tuberculosis
by: N. A. Nikiforenko, et al.
Published: (2021-08-01)

SIDE EFFECTS OF SECOND-LINE ANTITUBERCULOSIS DRUGS IN MULTI-DRUG RESISTANCE (MDR) TUBERCULOSIS PATIENTS
by: Nia Savitri Tamzil, et al.
Published: (2025-04-01)

Bridging gaps in tuberculosis control: addressing cross-border challenges between India and Pakistan
by: Harendra Kumar, et al.
Published: (2025-05-01)

A method for purifying and concentrating Mycobacterium tuberculosis in sputum specimens: The double-membrane filtration and concentration method (DMFCM)
by: Dingyi Liu, et al.
Published: (2025-08-01)